Poolbeg Pharma (STU:7JN) Ending Cash Position : €11.89 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma Ending Cash Position?

Poolbeg Pharma's Ending Cash Position for the quarter that ended in Jun. 2024 was €11.89 Mil.

Poolbeg Pharma's quarterly Ending Cash Position declined from Jun. 2023 (€16.46 Mil) to Dec. 2023 (€14.13 Mil) and declined from Dec. 2023 (€14.13 Mil) to Jun. 2024 (€11.89 Mil).

Poolbeg Pharma's annual Ending Cash Position declined from Dec. 2021 (€24.65 Mil) to Dec. 2022 (€18.62 Mil) and declined from Dec. 2022 (€18.62 Mil) to Dec. 2023 (€14.13 Mil).

Poolbeg Pharma Ending Cash Position Historical Data

The historical data trend for Poolbeg Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Ending Cash Position Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Ending Cash Position

24.65

18.62

14.13

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Ending Cash Position	Get a 7-Day Free Trial			22.01	18.62	16.46	14.13	11.89

Poolbeg Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Poolbeg Pharma's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	18.796	+	-4.668
	=	14.13

Poolbeg Pharma's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	14.385	+	-2.494
	=	11.89

Poolbeg Pharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (STU:7JN) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

POLB:UK 7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines